Skip to main content
Premium Trial:

Request an Annual Quote

NextGxDx Offering PreventionGenetics' Test Catalog

NEW YORK (GenomeWeb News) – NextGxDx will begin offering PreventionGenetics' test catalog through the NextGxDx platform under an agreement announced today.

The deal adds hundreds of new genetic tests "to the NextGxDx marketplace for easy search, comparison, and ordering," NextGxDx said. Financial and other terms of the deal were not disclosed.

"PreventionGenetics adds tremendous depth to our catalog and enhances the choice of genetic testing products available to health care providers through our platform," Judsen Schneider, NextGxDx scientific director, said in a statement. "Given their commitment to the research and development of new genetic testing products, we expect that catalog will continue to expand over time."

Nashville, Tenn.-based NextGxDx said last week it had raised $1 million in a private financing round.

The company offers an online platform that allows healthcare professionals to access listings of genetic tests from CLIA-certified laboratories, order them, and view the test results.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more